Back to Blog

Formus Platform Achieves International Certification

Formus Labs is proud to announce that we have recently been awarded ISO 13485 certification, following the successful completion of our Stage 2 quality systems audit. This represents a significant step toward achieving regulatory approval in international markets, with ISO certification a core requirement across key territories.

ISO 13485 has been noted as being the “world’s most popular standard for medical device quality management”, serving as a prerequisite for launching in territories such as Australia, Brazil, Canada, Japan, and the USA. Notably, the FDA has recently announced that ISO 13485 certification will serve as the basis for its quality system legislation moving forward.

“As a company with global ambition, achieving the ISO standard is a crucial building block in our product development and regulatory road map. These standards are of the highest order, designed to protect end-users and ensure a quality product output. We’re pleased to be able to confidently say that the Formus platform stands up to this widely-accepted international benchmark”, affirmed Formus CEO, Dr. Ju Zhang.

The adoption of ISO 13485 by the FDA, as part of its stated drive toward a global convergence of medical device regulatory processes, further solidifies the importance of ISO certification for global markets.  Part of achieving these standards involves putting effective processes in place to receive and act upon user feedback, toward the goal of optimizing both the safety and efficacy of our product. We remain committed to continuously improving the platform and are proud to receive this external validation of our approach.

The goal of the Formus platform has always been to be used by any surgeon, in any hospital, anywhere in the world.  With the achievement of this international certification, paired with our commitment to improvement, we are closer than ever to making this a reality.

More from the Lab

Formus Labs, a Pioneering Developer of Orthopedic Surgery Planning Technology, Hires Ex-Johnson & Johnson Executive, Polly Teevan, To Lead Global Commercial Strategy

Formus Labs, creator of the world's first fully-automated 3D planner for joint replacement surgeries, today announced it has hired Polly Teevan as Chief Marketing Officer. Teevan will oversee global commercial and marketing strategy, and lead Formus to expand its presence in the US and international markets leveraging her deep customer relationships, industry knowledge and commercial experience.

Read Story

Formus Labs Adds Seasoned Medical Technology Executives Lloyd McCann and Meraj Khan to Board of Directors

Formus Labs, creator of the world's first fully-automated 3D planner for joint replacement surgeries, today announced the appointments of Mercy Radiology and Clinics CEO, Dr Lloyd McCann, and Vice President of Market Development at BK Medical, Meraj Khan, to its Board of Directors. Each brings more than 15 years of international medical technology and healthcare experience in a variety of roles.

Read Story

Formus Labs Raises $5 Million to Automate Orthopedic Surgery Planning; Partners With Zimmer Biomet to Supercharge Global Launch

Formus combines AI and biomechanics to empower orthopedic surgeons with fully interactive 3D models to optimize the preoperative planning process

Read Story

Subscribe for the latest news and product updates

We will never share your email address with third parties.